Candriam SCA’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Candriam SCA’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-97,043	Closed	-$2.46M	–	858
2019 Q1	$2.46M	Buy	+97,043	New	+$1.72M	0.03%	451

Candriam SCA's NITE Position: Q2 2019 in Review

Candriam SCA sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 97,043 shares — an estimated $2.46M sold.

Candriam SCA first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $2.46M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Candriam SCA reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Candriam SCA sold 97,043 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $2.46M.
Candriam SCA first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
Candriam SCA's Nightstar Therapeutics plc American Depositary Shares position peaked at $2.46M in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.